JP7618239B2 - 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 - Google Patents

薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 Download PDF

Info

Publication number
JP7618239B2
JP7618239B2 JP2021553012A JP2021553012A JP7618239B2 JP 7618239 B2 JP7618239 B2 JP 7618239B2 JP 2021553012 A JP2021553012 A JP 2021553012A JP 2021553012 A JP2021553012 A JP 2021553012A JP 7618239 B2 JP7618239 B2 JP 7618239B2
Authority
JP
Japan
Prior art keywords
therapeutically active
patient
drug
dosing regimen
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021553012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022524083A (ja
JP2022524083A5 (https=
Inventor
ダイアン アール． モールド，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/028750 external-priority patent/WO2019209845A1/en
Application filed by Individual filed Critical Individual
Publication of JP2022524083A publication Critical patent/JP2022524083A/ja
Publication of JP2022524083A5 publication Critical patent/JP2022524083A5/ja
Priority to JP2024195155A priority Critical patent/JP2025020335A/ja
Application granted granted Critical
Publication of JP7618239B2 publication Critical patent/JP7618239B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2021553012A 2019-03-08 2020-03-09 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 Active JP7618239B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024195155A JP2025020335A (ja) 2019-03-08 2024-11-07 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962815825P 2019-03-08 2019-03-08
US62/815,825 2019-03-08
USPCT/US2019/028750 2019-04-23
US16/391,950 2019-04-23
PCT/US2019/028750 WO2019209845A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
US16/391,950 US20190326002A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
PCT/US2020/021742 WO2020185699A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024195155A Division JP2025020335A (ja) 2019-03-08 2024-11-07 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法

Publications (3)

Publication Number Publication Date
JP2022524083A JP2022524083A (ja) 2022-04-27
JP2022524083A5 JP2022524083A5 (https=) 2023-03-17
JP7618239B2 true JP7618239B2 (ja) 2025-01-21

Family

ID=72426742

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021553012A Active JP7618239B2 (ja) 2019-03-08 2020-03-09 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法
JP2024195155A Pending JP2025020335A (ja) 2019-03-08 2024-11-07 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024195155A Pending JP2025020335A (ja) 2019-03-08 2024-11-07 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法

Country Status (8)

Country Link
EP (1) EP3935639A1 (https=)
JP (2) JP7618239B2 (https=)
KR (1) KR102839034B1 (https=)
AU (2) AU2020239014A1 (https=)
CA (1) CA3132823A1 (https=)
IL (1) IL286145A (https=)
SG (1) SG11202109704UA (https=)
WO (1) WO2020185699A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12064664B2 (en) 2020-11-10 2024-08-20 Willowview Consulting, Llc Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations
US20220199266A1 (en) * 2020-12-10 2022-06-23 DataRobot, Inc. Systems and methods for using machine learning with epidemiological modeling
CN113643785B (zh) * 2021-07-22 2023-09-01 海南大学 基于dikw图谱的疫苗接种浓度确认方法
CN114765076A (zh) * 2022-04-18 2022-07-19 柳州市妇幼保健院 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN116453669B (zh) * 2023-06-14 2023-08-25 武汉大学中南医院 一种基于大数据的护理预测方法及装置
WO2025006459A1 (en) * 2023-06-29 2025-01-02 Prxcision, Inc. Machine learning for real-time decision support
CN118016237A (zh) * 2024-01-22 2024-05-10 南栖仙策(南京)高新技术有限公司 给药剂量确定方法、装置、电子设备及存储介质
CN120448609B (zh) * 2025-07-11 2025-09-16 上海斯丹姆医药开发有限责任公司 一种流感疫苗临床试验中的数据可视化方法及系统

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080008991A1 (en) 2000-09-15 2008-01-10 Kees Groen System and method for optimizing drug therapy for the treatment of diseases
JP2010532044A (ja) 2007-06-27 2010-09-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 患者生理学のモデル化に基づく各患者に固有の治療法を作成するためのシステムおよび方法
JP2013516680A (ja) 2010-01-04 2013-05-13 メイオウ ファウンデイション フォア メディカルエジュケイション アンド リサーチ 赤血球生成刺激剤（ｅｓａ）の投薬量決定
JP2013524355A (ja) 2010-04-07 2013-06-17 ノヴァディスカバリー 処置成果を予測するためのコンピュータベースシステム
JP2016500866A (ja) 2012-10-05 2016-01-14 ベイシエント エルエルシー 数学モデルの関数として患者特有の投与を提供するためのシステムおよび方法
US20160300037A1 (en) 2015-04-09 2016-10-13 Diane R. MOULD Systems and methods for patient-specific dosing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080008991A1 (en) 2000-09-15 2008-01-10 Kees Groen System and method for optimizing drug therapy for the treatment of diseases
JP2010532044A (ja) 2007-06-27 2010-09-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 患者生理学のモデル化に基づく各患者に固有の治療法を作成するためのシステムおよび方法
JP2013516680A (ja) 2010-01-04 2013-05-13 メイオウ ファウンデイション フォア メディカルエジュケイション アンド リサーチ 赤血球生成刺激剤（ｅｓａ）の投薬量決定
JP2013524355A (ja) 2010-04-07 2013-06-17 ノヴァディスカバリー 処置成果を予測するためのコンピュータベースシステム
JP2016500866A (ja) 2012-10-05 2016-01-14 ベイシエント エルエルシー 数学モデルの関数として患者特有の投与を提供するためのシステムおよび方法
US20160300037A1 (en) 2015-04-09 2016-10-13 Diane R. MOULD Systems and methods for patient-specific dosing

Also Published As

Publication number Publication date
SG11202109704UA (en) 2021-10-28
WO2020185699A1 (en) 2020-09-17
CA3132823A1 (en) 2020-09-17
KR20220002884A (ko) 2022-01-07
KR102839034B1 (ko) 2025-07-28
JP2022524083A (ja) 2022-04-27
IL286145A (en) 2021-10-31
JP2025020335A (ja) 2025-02-12
AU2020239014A1 (en) 2021-10-07
AU2025275175A1 (en) 2026-01-15
EP3935639A1 (en) 2022-01-12

Similar Documents

Publication Publication Date Title
US20240371491A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
JP7618239B2 (ja) 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法
JP7396680B2 (ja) 適応投与計画を修正するためのシステムおよび方法
US20230178203A1 (en) Systems and methods for patient-specific dosing
US20230187067A1 (en) Use of clinical parameters for the prediction of sirs
US10262112B2 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
WO2018201083A1 (en) System and method for predicting survival time
Al Faysal et al. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals
Morikubo et al. Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis
US20220383991A1 (en) Systems and methods for monoclonal antibody nomograms
Ueno et al. Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry
Vigueras et al. A PopPBPK-RL approach for precision dosing of benazepril in renal impaired patients
Kiltz et al. Optimizing Dose-Response Decisions in Psoriatic Arthritis via Causal Machine Learning: A Real-World Evaluation of Secukinumab Treatment
Chaiben et al. Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD
HK40079892A (en) Systems and methods for patient-specific dosing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230309

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230309

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240426

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241107

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241225

R150 Certificate of patent or registration of utility model

Ref document number: 7618239

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150